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There are few reliable predictors of response to antidepressant treatments. In the present investigation, we examined pretreatment
functional brain connectivity during reward processing as a potential predictor of response to Behavioral Activation Treatment for
Depression (BATD), a validated psychotherapy that promotes engagement with rewarding stimuli and reduces avoidance behaviors.
Thirty-three outpatients with major depressive disorder (MDD) and 20 matched controls completed two runs of the monetary incentive
delay task during functional magnetic resonance imaging after which participants with MDD received up to 15 sessions of BATD. Seed-
based generalized psychophysiological interaction analyses focused on task-based connectivity across task runs, as well as the attenuation of
connectivity from the first to the second run of the task. The average change in Beck Depression Inventory-II scores due to treatment was
10.54 points, a clinically meaningful response. Groups differed in seed-based functional connectivity among multiple frontostriatal regions.
Hierarchical linear modeling revealed that improved treatment response to BATD was predicted by greater connectivity between the left
putamen and paracingulate gyrus during reward anticipation. In addition, MDD participants with greater attenuation of connectivity
between several frontostriatal seeds, and midline subcallosal cortex and left paracingulate gyrus demonstrated improved response to
BATD. These findings indicate that pretreatment frontostriatal functional connectivity during reward processing is predictive of response to
a psychotherapy modality that promotes improving approach-related behaviors in MDD. Furthermore, connectivity attenuation among
reward-processing regions may be a particularly powerful endophenotypic predictor of response to BATD in MDD.
Neuropsychopharmacology (2017) 42, 831–843; doi:10.1038/npp.2016.179; published online 19 October 2016
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INTRODUCTION
Unipolar major depressive disorder (MDD) is the leading
cause of global burden among all psychiatric and neurolo-
gical disorders (Collins et al, 2011) and is one of the leading
contributors to global disease burden (Ferrari et al, 2013).
Despite the societal costs of MDD, the overall efficacy of
antidepressant treatments has not improved substantially in
recent years (Undurraga and Baldessarini, 2012): first-line
FDA-approved pharmacotherapies demonstrate average
response rates of 54 vs 37% for placebo (Levkovitz et al,
2011), with similar response rates to psychotherapy (Butler
et al, 2006). Given the suboptimal response to first-line MDD
treatments, there has been a growing emphasis on develop-
ing methods to match specific subgroups of patients with
optimal treatment options (eg, Dunlop et al, 2012; McGrath
et al, 2013).
To date, one of the most consistent neural aberrations in
MDD is differences in functional neural responses to rewards
that may contribute to the core symptom of anhedonia in
MDD (Phillips et al, 2015). MDD is characterized by
decreased responsiveness of frontostriatal brain regions to
rewarding stimuli, including decreased anticipation of
forthcoming rewards, reduced pleasure derived from reward
presentation, and impaired reward-based learning (eg,
Admon and Pizzagalli, 2015 and Der-Avakian and Markou,
2012). Recent efforts to understand the pathophysiology of
MDD and treatment response in MDD have shifted from
focus on brain activation patterns to identifying distributed
synchronous brain networks implicated in core symptom
dimensions of MDD (Kaiser et al, 2015; Northoff, 2016), and
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a significant body of this research has addressed resting state
connectivity predictors of antidepressant treatment response
(see Dichter et al (2014) for a review). However, consistent
with the NIMH Research Domain Criteria initiative,
focusing on responses to specific classes of stimuli may be
particularly useful for identifying the clinically and patho-
physiologically meaningful MDD endophenotypes as a
means to parse the heterogeneity of MDD. Examining
responses to rewards is one such approach, and in the
present study, we investigated whether pretreatment func-
tional brain connectivity during reward processing predicted
response to Behavioral Activation Treatment for Depression
(BATD) psychotherapy using functional magnetic resonance
imaging (fMRI). BATD was originally developed to amelio-
rate symptoms of MDD by promoting sustained interactions
with potential reinforcers and inhibiting avoidance behaviors
(Hopko et al, 2003; Jacobson et al, 2001), and in this regard,
BATD is particularly well suited to ameliorate MDD
symptoms overall as well as anhedonia symptoms specifi-
cally. In addition, given its specific focus on increased
reward-oriented behaviors, BATD provides an ideal mechan-
istic probe to investigate neural mechanisms related to
reward processing and anhedonia in MDD. We recently
reported the task-related brain activation results from this
sample (Carl et al, 2016), and the focus of the present
investigation was to investigate task-related connectivity
patterns as potential predictors of response to treatment.
Given prior findings showing linkages between anhedonia
and decreased connectivity of the striatum with subcortical
and prefrontal brain regions in MDD (eg, Redlich et al,
2015), our primary hypotheses were that pretreatment
frontostriatal connectivity would predict the magnitude of
clinical response to BATD. However, not all neuroimaging
studies have consistently reported decreased frontostriatal
response to rewards in MDD (Knutson et al, 2008;
Mitterschiffthaler et al, 2003; Schaefer et al, 2006). One
recent conceptualization of hedonic functioning in MDD
that potentially addresses such inconsistencies is that MDD
may be characterized by greater attenuation of response to
rewards over time (Pizzagalli et al, 2008). In support of this
framework, an investigation of hedonic response duration
reported that participants with MDD demonstrated de-
creased capacity to sustain nucleus accumbens (NAcc)
activation during conscious upregulation of positive emo-
tions across the scan session (Heller et al, 2009). Further-
more, the degree of decreased NAcc activity predicted the
magnitude of self-reported positive affect in the MDD
sample. In a follow-up study, Heller and colleagues reported
that the magnitude of change in positive affect following
2 months of treatment with fluoxetine or venlafaxine was
associated with sustained activation (ie, less attenuation) of
the NAcc and connectivity of the NAcc with the left middle
frontal gyrus during upregulation of positive emotions. Thus,
a secondary aim of the present study was to evaluate whether
attenuation of functional connectivity during reward proces-
sing predicted response to BATD. One hypothesis is that
relatively preserved reward network function would be
predictive of better response to BATD. That is, greater
capacity to maintain frontostriatal connectivity (ie, less
attenuation) to rewards over time may capitalize on patients’
strengths, allowing them to more easily engage with
treatment targets, thereby reducing symptoms. An
alternative, competing hypothesis is that greater deficits in
reward processing (ie, greater connectivity attenuation to
rewards over time) would be predictive of more favorable
treatment response. Because BATD is a treatment that
targets reward-processing deficits, patients with greater
impairment may benefit the most, reflecting a remediation
of deficits following treatment. By presenting two consecu-
tive runs of the reward task, we were able to evaluate changes
in neural connectivity from the first and second task run as
potential predictors of BATD response, and thereby test
these competing hypotheses. We were specifically interested
in whether changes in frontostriatal connectivity between
task runs would predict declines in symptoms of depression,
and in particular anhedonia, given the role of frontostriatal
connectivity in the pathophysiology of anhedonia (Forbes
and Dahl, 2012; Heller et al, 2009, 2013).
MATERIALS AND METHODS
Participants
As described in Carl et al (2016), this protocol was approved
by the Institutional Review Boards at Duke University
Medical Center and the University of North Carolina at
Chapel Hill, and all participants provided written informed
consent. Participants with MDD were recruited via the
Cognitive Behavioral Research and Treatment Program at
Duke University Medical Center and control participants
were recruited via listservs at Duke University and UNC-
Chapel Hill. The MDD and control groups participated in
the MRI scan session, after which the MDD group began
psychotherapy by study clinicians who received weekly
supervision and team didactics in BATD. Up to 15 sessions
of BATD were offered; MDD participants received an
average of 11.67 (SD= 4.40; range: 2–15) weekly sessions.
Early responders were given the option to end therapy after a
minimum of eight sessions and non-responders received the
maximum number of sessions before being referred to the
community for additional treatment. Notably, controlling for
the number of weeks in treatment did not alter any results
presented in this manuscript. A description of BATD is
provided in Supplementary Materials I.
Participants in the MDD group met DSM-IV criteria for a
current episode of MDD using the Structured Clinical
Interview for DSM-IV-TR Axis I Disorders (SCID; First
et al, 2002) and scored ⩾ 15 on the Hamilton Rating Scale for
Depression (HAMD; Hamilton, 1960; Miller et al, 1985),
given by trained clinicians under the supervision of a
licensed psychologist. Control group participants scored ⩽ 6
on the HAMD and did not meet criteria for a current or
lifetime episode of a mood disorder. Exclusion criteria
included: (1) history of psychosis or mania; (2) active
suicidal ideation, (3) evidence of organicity, (4) magnetic
resonance imaging contraindication, (5) history of neurolo-
gical injury or disease, (6) current pregnancy, and, in the
MDD group, (7) current mood, anxiety, psychotic, or
substance abuse disorder beyond unipolar MDD or
dysthymia.
Thirty-eight outpatients with MDD (11 male; mean (SD)
age= 33 (7.1)) and 20 matched controls (6 male; mean (SD)
age= 31 (8.8)) enrolled. Two MDD participants did not
return for psychotherapy after the first imaging session and
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were excluded from analyses. Three MDD participants
taking psychoactive medications were also excluded from
analyses. Thus, the final sample included 33 outpatients
with MDD and 20 nondepressed control participants.
Of the final sample, 13 MDD participants discontinued
treatment early (6 responders (18%); 7 non-responders
(21%)). Groups did not differ in age, estimated IQ (measured
by the North American Adult Reading Test (Blair and
Spreen, 1989; NAART), or gender distribution, p’s40.32 (see
Supplementary Materials II for participant characteristics).
Participants completed a number of different imaging
protocols, and results of resting state scans from these
control participants and 24 MDD participants have been
reported previously (Crowther et al, 2015).
Monetary Incentive Delay fMRI Task
As described in Carl et al, 2016, during scanning,
participants completed two runs of the Monetary Incentive
Delay (MID) task (Knutson et al, 2001). Participants
practiced the fMRI task outside the scanner before the scan
session. During this practice session, participant-specific
average reaction times were used to adjust starting reaction
times during the scans. Each trial consisted of: (1) a 2000 ms
cue that indicated whether a fast enough response (a ‘hit’) to
the forthcoming target bullseye could result in a ‘reward’ (a
triangle) or ‘no reward’ (a circle); (2) a delay period during
which a crosshair was presented for 2000–2500 ms (‘antici-
pation phase’); (3) a target bullseye that required a speeded
button press presented for up to 500 ms; (4) 3000 ms of
feedback that indicated whether that trial resulted in a
‘reward’ or not (‘outcome phase’); and (5) a variable length
ITI crosshair presented such that the total duration of each
trial was 12 s. Potential reward and non-potential reward
trials were aperiodic and pseudorandomly ordered (Knutson
et al, 2000). Participants could win $2 per trial and were
given feedback about the amount of money won on each trial
(eg, ‘+$2’). Coincident with feedback, a cumulative total of
dollars won within the run was presented. Participants were
instructed to respond to target bullseye as quickly as possible,
and outcomes were contingent on reaction times. The task
was adaptive such that participants were successful on
approximately two-third of trials. Each 8-min run contained
40 trials: 20 were potential reward trials and 20 were non-
reward trials. Functional connectivity during the anticipation
(delay period) and outcome (feedback period) phases were
evaluated separately.
Imaging Methods and fMRI Preprocessing
Functional images were acquired at the Duke-UNC Brain
Imaging and Analysis Center (BIAC) on a General Electric
(Waukesha, WI) MR750 3.0 T scanner equipped with
50 mT/m gradients (200 T/m/s slew rate) and an eight-
channel head coil for parallel imaging. High-resolution
T1-weighted anatomical images were acquired with 162
axial slices using a FSPGR pulse sequence (TR= 7.584 ms;
TE= 2.936 ms; FOV= 256 mm; image matrix= 256× 256;
voxel size= 1× 1 × 1mm; flip angle= 12°) used for normal-
ization and coregistration. This structural image was aligned
in a near axial plane defined by the anterior and posterior
commissures. Whole-brain functional images were acquired
using a spiral-in SENSE sequence (TR= 1500 ms;
TE= 30 ms; FOV= 240 mm; image matrix, 64 × 64; flip
angle= 60°; voxel size, 3.75× 3.75× 4.0 mm; 34 axial slices)
to reduce susceptibility artifacts and recover signal in orbital
frontal regions (Pruessmann et al, 2001; Truong and Song,
2008). A semi-automated high-order shimming ensured
global field homogeneity.
The first four volumes of each functional run were
discarded. Data were preprocessed using FSL version 5.0.1
(Oxford Centre for Functional Magnetic Resonance Imaging
of the Brain (FMRIB), Oxford University, UK). Preproces-
sing was applied in the following steps: (i) brain extraction
for non-brain removal (Smith et al, 2004), (ii) motion
correction using MCFLIRT (Smith, 2002), (iii) spatial
smoothing using a Gaussian kernel of FWHM 5mm, (iv)
mean-based intensity normalization of all volumes by the
same factor, and (v) high-pass filtering (Jenkinson et al,
2002). Functional images of each participant were co-
registered to structural images in native space, and struc-
tural images were normalized into a standard stereotaxic
space (Montreal Neurological Institute) for intersubject
comparison. The same transformation matrices used
for structural-to-standard transformations were then used
for functional-to-standard space transformations of
co-registered functional images. All registrations used an
intermodal registration tool (Jenkinson et al, 2002; Smith
et al, 2004). Voxel-wise temporal autocorrelation was
estimated and corrected using FMRIB’s Improved Linear
Model (Jenkinson and Smith, 2001).
Treatment Outcome Measures
Treatment outcomes were evaluated by the Beck Depression
Inventory-II (BDI; Beck et al, 1996), collected at the scan
session, every 2 weeks during treatment, and at the last
psychotherapy session. BDI scores of 0–13 indicate minimal
MDD symptoms, 14–19 indicates mild MDD symptoms,
20–28 indicates moderate MDD symptoms, and 29–63 indi-
cates severe MDD symptoms (Beck et al, 1996). The BDI
provides an overall measure of MDD severity and includes
items that tap multiple MDD symptom dimensions. We
examined BDI total scores, as well as BDI anhedonia subscale
scores derived from items 4, 12, 15, and 21 (Joiner et al,
2003). Reliability of the BDI was evaluated in a multilevel
framework as described by Cranford et al, 2006. Reliabilities
of between-person differences across all time points as
measured using the BDI total score (RKF= 0.91) and
anhedonia scale (RKF= 0.95) were excellent; reliability of
change over time was also acceptable for both the total score
(RC= 0.86) and the anhedonia subscale (RC= 0.71).
fMRI Data Analysis
Task-based functional connectivity during reward anticipation
and outcome phases was analyzed using a generalized
psychophysiological interaction (gPPI) approach due to its
improved power, sensitivity, and specificity in detecting a
context-dependent functional connectivity (Cisler et al, 2014;
McLaren et al, 2012). We used a region-of-interest (ROI)
approach to target canonical reward-processing regions. ROI
seeds included the NAcc, caudate, putamen, frontal medial
cortex, orbitofrontal cortex (OFC), and anterior cingulate
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cortex. These ROIs were defined using the Harvard-Oxford
subcortical and cortical structural probabilistic atlases. Frontal
medial cortex and anterior cingulate cortex were divided into
left and right hemispheric regions using a custom MATLAB
script. In addition, a striatum ROI was constructed by
combining the caudate, putamen, and NAcc masks. These
ROIs are shown in Supplementary Materials III.
Voxel-wise models evaluated whole-brain connectivity
with these seeds. For each participant, mean fMRI time
courses (ie, physiological regressors) were extracted from
seed regions for each task run using fslmeants in FSL, then
multiplied by each psychological regressor of interest (ie, task
condition: reward and no reward) to form the PPI
interaction terms. The gPPI model included physiological
and psychological regressors, as well as their interaction
terms to describe the unique effect of these interactions
above and beyond the main effects of seed time courses and
task conditions. Our primary contrast of interest evaluated
the difference between connectivity during reward vs non-
reward trials (reward4non-reward) for both anticipation
and outcome phases of the task. This allows for the
characterization of connectivity patterns specific to reward
trials during each of these task phases.
Group differences were modeled two ways. First, group
differences were evaluated with respect to seed-based
connectivity across both task runs (‘global connectivity’).
Second, group differences in changes in connectivity over time
were evaluated with respect to the contrast of (run 14run 2;
‘connectivity attenuation’). Thus, connectivity attenuation is
defined as the reduction in functional connectivity from run 1
to run 2. Both approaches used mixed effects analyses with
Bayesian estimation techniques, using FMRIB Local Analysis
of Mixed Effects (Smith et al, 2004). Resulting images were
thresholded using Z42.3 with a corrected cluster significance
threshold of po0.05. This method of cluster correction,
implemented via the cluster thresholding option within FSL
FEAT, compares each cluster’s estimated significance (from
Gaussian random field theory) with the cluster probability
threshold to eliminate clusters below this threshold. Between-
group comparisons were restricted to clusters within corticos-
triatal regions generated by combining all reward-processing
ROIs into a single mask. Clusters were then thresholded at
Z42.58 or po0.005 (corrected) with a minimum contiguous
cluster size of 8. Cluster localizations were based on Harvard–
Oxford cortical and subcortical structural probabilistic atlases,
with Brodmann area identification via Talairach Daemon in
FSLView v3.1.8.
Analytic Plan for Predicting Treatment Response from
Functional Connectivity
We used hierarchical linear models (HLMs) to examine
whether clusters indicating group differences in connectivity
predicted treatment response measured via nine BDI
assessments over 15 weeks using SAS PROC MIXED 9.4
(SAS Institute, Cary, NC, USA), with treatment week at level
1 and person at level 2. Treatment week was a continuous
time variable and was uncentered. We specified an
autoregressive (week 2) covariance structure for within-
person errors. Individual coefficients were presented as
gamma weights that were analogous to unstandardized
beta coefficients in standard regression, representing the
estimated change in the dependent variable given a one-unit
increase in the predictor. For further details about our HLM
approach, please see Supplementary Materials IV.
Motion Correction
Motion can have a particularly strong impact on connectivity
analyses (Power et al, 2012). All runs from all participants
had motion that was o5 mm along any of the six possible
axes, ie, x, y, z, pitch, yaw, and roll (with the exception of one
dimension for a single run for one control participant).
There were no significant effects of group or run for mean or
max absolute head motion along any of the six possible axes,
all p’s4.05. Furthermore, we tested for group differences in
absolute root mean squared (RMS) displacement. Results
showed there was no significant difference between MDD
and Control participants across runs, p40.05. Motion plots
and analyses can be viewed in Supplementary Materials V.
RMS displacement was also entered as a covariate in
group-level analyses for seed-based connectivity models
where clusters were predictive of treatment response. Tables
including RMS displacement as a covariate are presented in
the Supplementary Materials (Tables 1 and 2). Because
there were no between-group differences in RMS
displacement and because the inclusion of this covariate in
group-level analyses did not meaningfully alter findings
(including HLM models predicting treatment response), this
covariate was not included in the other group-level
connectivity models.
Table 1 Group Differences in Global Functional Connectivity
(ie, across runs)
Anticipation phase:
Seed Region (BA) MNI coordinates k Peak
z-score
X Y Z
MDD4CON
Left caudate ACC (BA 9/32) − 4 26 24 290 3.83
ACC (BA 24) 6 14 28 22 3.00
R paracingulate gyrus
(BA 24/32)
12 12 44 61 3.63
L ACC − 2 2 38 37 3.06
Paracingulate gyrus
(BA 6/8)
8 26 42 21 3.43
MDDoCON
Left OFC L putamen − 28 − 2 12 13 3.14
R caudate 18 14 14 21 3.48
R caudate 8 2 16 103 3.71
L caudate − 16 14 16 19 3.20
L caudate − 20 − 2 20 79 3.55
Right OFC L caudate − 12 − 16 24 54 3.21
Abbreviations: k, number of voxels in each cluster; BA, Brodmann Area;
R, right, L, left; ACC, anterior cingulate cortex; OFC, orbitofrontal cortex.
All clusters are thresholded at po0.005 (corrected), 48 contiguous
voxels; MNI coordinates reflect the maximum voxel of intensity for each
cluster.
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Table 2 Group Differences in Functional Connectivity Attenuation (ie, run 14run 2)
Seed Region (BA) MNI coordinates k Peak z-score
X Y Z
Anticipation phase:
MDD4CON
Left striatum L OFC/FP/FMC (BA 11/47) − 24 30 − 20 292 4.12
R OFC/subcallosal cortex/FMC (BA 10/11/47) 12 44 − 12 335 3.71
L OFC (BA 25) − 10 6 − 20 29 3.11
R FMC/FP (BA 11) 4 52 − 24 34 3.36
Right striatum R OFC/subcallosal cortex/temporal pole (BA 25/47) 18 8 − 26 646 4.03
L OFC/temporal pole (BA 11/25/47) − 22 30 − 20 508 4.46
R FP 10 38 − 28 15 3.08
R FMC/FP (BA 11) 4 52 − 24 22 3.21
Left NAcc Paracingulate gyrus/FP (BA 9/10) − 12 54 8 225 3.77
Left caudate L OFC/FP (BA 11/47) − 22 26 − 24 162 3.71
L subcallosal cortex − 10 20 − 18 9 2.80
Right caudate R OFC/subcallosal cortex (BA 25/47) 10 16 − 16 272 3.54
L OFC/subcallosal cortex/FP (BA 11/25/47) − 22 26 − 24 402 4.29
R FMC/FP 10 38 − 28 12 2.86
R FMC 10 36 − 16 81 3.42
Left putamen L OFC (BA 11/47) − 30 36 − 22 373 4.13
R OFC/subcallosal cortex/temporal pole (BA 5/47) 14 24 − 18 392 3.96
Subcallosal cortex (BA 11) − 4 24 − 26 10 2.90
R FMC/FP (BA 11) 4 52 − 24 41 3.67
L FP (BA 11) − 12 56 − 24 21 3.25
FMC 0 46 − 22 9 2.76
Right putamen L OFC/temporal pole (BA 11/25/47) − 22 30 − 20 462 4.59
R OFC/subcallosal cortex/temporal pole (BA 25/47) 14 24 − 18 573 4.47
R temporal pole/OFC (BA 47) 32 12 − 20 104 3.74
Left ACC R OFC/subcallosal cortex (BA 11/25/47) 18 20 − 16 456 4.18
Right ACC R OFC (BA 25) 14 22 − 18 157 3.98
L OFC/FP (BA 11/47) − 24 30 − 20 121 3.56
L FP − 10 44 − 22 10 3.12
R FMC/FP (BA 10/11) 12 44 − 14 212 4.15
Right FMC ACC (BA 24/32) 10 36 12 74 3.47
Paracingulate gyrus (BA 32) − 12 36 26 15 3.08
Outcome phase:
MDD4CON
Right striatum R OFC/subcallosal cortex (BA 25/47) 14 24 − 18 227 3.86
Left NAcc L paracingulate gyrus/FP (BA 10) − 10 56 8 60 3.63
Paracingulate gyrus (BA 32) − 14 34 26 10 3.03
MDDoCON
Left striatum R putamen 34 0 − 4 41 3.55
Right striatum R putamen 24 − 22 12 57 3.56
Right NAcc R putamen 34 0 − 4 105 3.32
R inferior frontal gyrus (BA 44/45) 48 22 6 40 3.91
R insula 34 − 22 4 18 3.38
Left caudate R putamen 36 − 2 − 4 33 3.27
R putamen 26 − 14 6 68 3.34
R insula 36 − 6 6 15 3.38
Right caudate R putamen 34 − 22 4 191 3.91
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RESULTS
Effects of Treatment Week on Depression Scores
Treatment resulted in highly significant reductions in BDI
total scores (pretreatment mean (SD)= 25.27 (8.52), post-
treatment mean (SD)= 14.73 (9.96), po0.001) and BDI
anhedonia subscale scores (pretreatment mean (SD)= 4.91
(2.26), post-treatment mean (SD)= 2.87 (2.00), po0.001).
This is consistent with results from HLM models that showed
a significant main effect of treatment week on BDI total and
BDI anhedonia subscale scores, with both showing highly
significant linear decreases over time (effect of treatment week
on BDI total scores: γTREATMENT WEEK=− 0.95, SE= 0.12,
t(202)=− 7.69, p=o0.0001; and on BDI anhedonia subscale
scores: γTREATMENT WEEK=− 0.18, SE= 0.031, t(202)=− 5.86,
p=o0.0001). Supplementary Material VI illustrates biweekly
individual patient and group-averaged BDI scores during the
course of BATD treatment.
Task-Related Functional Connectivity (gPPI) Results
Group differences in global connectivity (ie, averaged across
runs). Group differences in task-dependent global func-
tional connectivity (ie, across runs) are illustrated in Table 1.
During the anticipation phase of the task, the MDD group
exhibited increased connectivity, relative to controls, be-
tween the left caudate seed and several clusters in the
anterior cingulate and paracingulate gyrus, and decreased
connectivity between the OFC seeds and clusters in the left
and right caudate and left putamen. No group differences
were evident in the outcome phase of the task.
Group differences in connectivity attenuation (ie, reduc-
tions from run 1 to run 2). Group differences in task-
dependent connectivity attenuation (run 14run 2) during
the anticipation and outcome phases of the MID task
are shown in Table 2 and select results are illustrated in
Figure 1. During the anticipation phase of the task, there
were multiple clusters revealing relatively greater attenuation
of connectivity in the MDD group in medial anterior
portions of the left and right prefrontal cortex, including
frontal medial cortex, frontal pole, and OFC with numerous
frontostriatal seed regions (eg, striatum and anterior
cingulate). In contrast, there were only three clusters
showing significantly greater connectivity attenuation in
the outcome phase of the MID task in the MDD group: the
right striatum seed with a cluster containing portions of right
OFC and subcallosal cortex, and the left NAcc seed with
clusters in the paracingulate gyrus.
During the outcome phase of the MID task, there
were also multiple clusters where the MDD group exhi-
bited relatively less connectivity attenuation. The left and
right striatum seeds, the right NAcc seed, and the left and
right caudate seeds showed less attenuation of connec-
tivity with overlapping clusters in the right putamen.
Furthermore, the right caudate seed, the left frontal medial
cortex seed, and the left OFC seed also showed signifi-
cantly less connectivity attenuation with clusters in anterior
and posterior portions of the cingulate cortex and the
precentral gyrus.
Task-Related Connectivity as a Predictor of Treatment
Response
For clusters that differentiated groups in terms of global
connectivity (Table 1) and connectivity attenuation
(Table 2), HLM models were used to evaluate whether
individual differences in pretreatment functional connectiv-
ity predicted the slope of change in BDI total and anhedonia
scores over the course of BATD.
Table 2 Continued
Seed Region (BA) MNI coordinates k Peak z-score
X Y Z
Precentral gyrus/Posterior cingulate 14 − 20 44 116 3.52
Posterior cingulate (BA 31) 4 − 28 40 9 3.03
Precentral gyrus (BA 31) − 2 − 24 50 15 3.67
Left FMC Inferior frontal gyrus 50 16 2 12 3.06
Posterior cingulate (BA 23) 6 − 26 28 11 2.87
ACC (BA 24) 4 − 2 36 31 3.09
Posterior cingulate 12 − 20 42 15 3.23
Left OFC R putamen 26 − 20 6 13 3.05
Posterior cingulate 4 − 18 36 55 3.88
ACC (BA 24) − 8 − 8 46 122 3.37
Precentral gyrus (BA 31) 14 − 20 44 35 3.57
Paracingulate gyrus (BA 32) 6 10 44 9 2.84
ACC (BA 31) 4 − 8 46 9 3.05
Precentral gyrus (BA 31) − 2 − 22 50 14 3.01
Abbreviations: k, number of voxels in each cluster; BA, Brodmann Area; R: right, L, left; ACC, anterior cingulate cortex; FMC, frontal medial cortex; FP, Frontal Pole;
OFC, orbitofrontal cortex; NAcc, nucleus accumbens.
Clusters are thresholded at po0.005 (corrected), 48 contiguous voxels; MNI coordinates reflect the maximum voxel of intensity for each cluster.
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Global Connectivity as a Predictor of Treatment Response
Prediction of change in BDI total and anhedonia scores
from connectivity between the left caudate seed and right
paracingulate gyrus. As illustrated in Figure 2, one cluster
that reflected group differences in pretreatment global
connectivity was predictive of treatment response: during
reward anticipation, greater connectivity between the left
caudate seed and right paracingulate gyrus (BA24/32) was
associated with greater declines in BDI total and anhedonia
subscale scores during treatment (BDI total score:
γCONNECTIVITY*TREATMENT WEEK=− 0.39, SE= 0.19, t(186)=
− 2.02, p= 0.045; BDI anhedonia subscale score:
γCONNECTIVITY*TREATMENT WEEK=− 0.094, SE= 0.031,
t(187)=− 3.10, p= 0.0023). Pseudo-R2 calculations indi-
cated that this connectivity metric accounted for ~ 7.6% of
the between-person variance in the within-person effect
of treatment week on BDI total scores, and ~ 25% of the
between-person variance in the within-person effect of
treatment week on BDI anhedonia subscale scores. Figure 2
illustrates the trends for BDI total scores, and BDI anhedonia
subscale scores reflect the same pattern (not shown). The
direction of this effect reflects that patients whose global
connectivity patterns were more different from controls (ie,
those with greater pretreatment connectivity) fared better
after treatment.
Connectivity Attenuation as a Predictor of Treatment
Response
Individual differences in connectivity attenuation between
several regions pairs also predicted treatment response. All
significant models were for clusters that reflected greater
attenuation of connectivity in the MDD group relative to the
control group.
Prediction of change in BDI total scores from connectivity
attenuation between the right putamen seed and right
OFC /temporal pole. As illustrated in Figure 3, during the
anticipation phase of the MID task, less connectivity
attenuation between the right putamen seed and right OFC
/temporal pole (BA47) was associated with greater declines
in BDI total scores during treatment (γCONNECTIVITY
DIFFERENCE*TREATMENT WEEK= 0.40, SE= 0.14, t(185)= 2.80,
po0.0001); individual differences in connectivity attenuation
of these regions accounted for 16% of the variance in BDI
total score change during treatment. The direction of this
effect reflects that patients whose connectivity attenuation
patterns were more similar to controls (ie, those with less
dropoff in connectivity between run 1 and run 2) fared better
after treatment.
Prediction of change in BDI total scores from connectivity
attenuation between the left NAcc seed and right
paracingulate gyrus. As illustrated in Figure 4, during the
reward outcome phase of the MID task, greater connectivity
attenuation between the left NAcc seed and paracingulate
gyrus (BA 32) was associated with greater declines in BDI
total scores during treatment (γCONNECTIVITY DIFFERENCE*-
TREATMENT WEEK=−0.41, SE=0.16, t(185)=− 2.51, p= 0.013);
individual differences in connectivity attenuation of these
regions accounted for 4.7% of the between-person variance
in BDI total score change across treatment (Figure 4). The
direction of these effects indicates that patients whose
connectivity attenuation patterns were less similar to
controls (ie, those with greater dropoff in connectivity
between run 1 and run 2) fared better after treatment.
Prediction of change in BDI total scores from connectivity
attenuation between the right frontal medial cortex seed
and paracingulate gyrus. In addition, greater connectivity
attenuation between the right frontal medial cortex seed and
paracingulate gyrus (BA 32) during reward anticipation
predicted greater reductions in BDI total scores across
treatment (γCONNECTIVITY DIFFERENCE*TREATMENT WEEK=
− 0.36, SE= 0.14, t(185)=− 2.58, p= 0.010). Individual dif-
ferences in connectivity attenuation of the right frontal
medial cortex seed and paracingulate gyrus (BA32) ac-
counted for 11% of the between-person variance in BDI total
score change. The direction of these effects indicates that
patients whose connectivity attenuation patterns were less
Figure 1 Group differences in task-dependent connectivity attenuation (run 14run 2) during the anticipation and outcome phases of the MID task.
Relative to the control group, the MDD group showed greater connectivity attenuation (run 14run 2) with clusters in the orbitofrontal cortex and subcallosal
cortex and (a) the left striatum seed during reward anticipation, (b) the right striatum seed during reward anticipation, and (c) the right striatum seed during
reward outcomes. Note that across all three contrast maps, clusters are within the orbitofrontal cortex and subcallosal cortex. A full color version of this figure
is available at the Neuropsychopharmacology journal online.
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similar to controls (ie, those with greater dropoff in
connectivity between run 1 and run 2) fared better after
treatment.
Prediction of change in BDI anhedonia scores from
connectivity attenuation between the left putamen seed and
subcallosal cortex. Greater connectivity attenuation be-
tween the left putamen seed and subcallosal cortex (BA11)
during reward anticipation (not shown) was also associated
with greater declines in BDI anhedonia subscale scores
(γCONNECTIVITY DIFFERENCE*TREATMENT WEEK=− 0.08, SE=
0.025, t(186)=− 3.20, p= 0.0016). Individual differences in
connectivity attenuation accounted for 33% of the variance
in BDI anhedonia subscale score change across treatment.
The direction of these effects indicates that patients whose
connectivity attenuation patterns were less similar to
controls (ie, those with greater dropoff in connectivity
between run 1 and run 2) fared better after treatment.
DISCUSSION
The purpose of this study was to investigate whether
pretreatment functional connectivity during a reward-
processing task predicted response to BATD in outpatients
with MDD. BATD promotes interactions with potentially
rewarding activities and decreases withdrawal behaviors
(Hopko et al, 2003; Jacobson et al, 2001), thereby making it
an ideal mechanistic probe to evaluate relations between
connectivity in reward-processing brain regions and re-
sponse to a treatment modality that increases responses to
motivationally relevant information. The clinical effective-
ness of BATD in the current study was consistent with prior
trials (Dichter et al, 2009; Hopko et al, 2003): average BDI
scores declined 10.54 points, a clinically meaningful response
(Jacobson and Truax, 1991), a shift from moderate to mild
depressive symptoms.
We evaluated both global connectivity (ie, across task
runs) and connectivity attenuation (ie, reductions in
connectivity from run 1 to run 2). We found increased
global connectivity in the MDD group during reward
anticipation between the left caudate seed and several
clusters in the anterior cingulate and paracingulate gyrus,
and decreased global connectivity between the OFC seeds
and clusters in the left and right caudate, and left putamen,
whereas there were no group differences during the outcome
phase of the task. There was also greater connectivity
attenuation in the MDD group in medial anterior portions of
the left and right prefrontal cortex, including frontal medial
cortex, frontal pole, and OFC, during reward anticipation
and between striatal seeds and OFC, subcallosal cortex, and
paracingulate gyrus during reward outcomes.
Group differences in connectivity between mid-frontal
brain regions and the striatum in MDD are consistent with
other investigations using resting state approaches (Kaiser
et al, 2015) as well as prior reports in participants with
remitted MDD (Admon et al, 2015; Morgan et al, 2016), but
extend this literature to the context of a reward-processing
task (Satterthwaite et al, 2015). These results also extend
prior findings on frontostriatal connectivity attenuation in
MDD (Heller et al, 2013) and highlight the importance of
Figure 2 Within the MDD group, greater global connectivity between the left caudate (seed) and right paracingulate gyrus (BA 24/32) during reward
anticipation predicted greater improvement in BDI total scores over the course of BATD treatment. The plot is a graphical illustration of the significant
interaction between pretreatment connectivity and time predicting change in BDI scores from the HLM models. The lines represent the expectation for
change in an individual who is one SD below the mean and one SD above the mean. Note the lines are model-based estimates and do not represent averages
but rather ranges of brain connectivity variability. The brain image indicates the seed region above and the connecting cluster beneath. The bar graph illustrates
connectivity estimates. A full color version of this figure is available at the Neuropsychopharmacology journal online.
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Figure 3 Within the MDD group, less connectivity attenuation between the right putamen (seed) and right orbitofrontal cortex/temporal pole (BA 47)
during reward anticipation predicted greater improvement in BDI total scores over the course of BATD treatment. The plot is a graphical illustration of the
significant interaction between pretreatment connectivity and time predicting change in BDI scores from the HLM models. The lines represent the expectation
for change in an individual who is one SD below the mean and one SD above the mean. Note the lines are model-based estimates and do not represent
averages but rather ranges of brain connectivity variability. The brain image indicates the seed region above and the connecting cluster beneath. The bar graph
illustrates connectivity estimates. A full color version of this figure is available at the Neuropsychopharmacology journal online.
Figure 4 Within the MDD group, greater connectivity attenuation between the left nucleus accumbens (seed) and paracingulate gyrus (BA 32) during
reward outcomes predicted greater improvement in BDI total scores over the course of BATD treatment. Findings between the left putamen (seed) and
subcallosal cortex (BA 11) during reward anticipation and the right frontal medial cortex (seed) and paracingulate gyrus (BA 32) during reward anticipation
followed the same pattern. A full color version of this figure is available at the Neuropsychopharmacology journal online.
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examining the temporal dynamics of neural responses for
understanding the pathophysiology of MDD (Heller et al,
2009; Pizzagalli et al, 2008). The localization of many
connectivity clusters to the OFC, cingulate cortex, and
subcallosal cortex further underscores the relevance of
altered connectivity in these regions to MDD etiology
(Chai et al, 2015; Choi et al, 2015).
We used HLMs to examine whether clusters reflecting
group differences in global connectivity and connectivity
attenuation in frontostriatal regions predicted response to
BATD. The majority of findings showed that patients whose
brain connectivity patterns were more divergent than
controls responded better to treatment, as evidenced by
greater declines in BDI total and/or anhedonia subscale
scores. Furthermore, significant clusters were largely
localized to regions within/bordering the dorsal anterior
cingulate cortex (dACC) and medial prefrontal cortex
(mPFC). Both regions have central roles in reward-based
decision-making and behavior. The dACC is involved in
estimating value of potential rewards and determining the
worth of investing cognitive control to a given action
(Shenhav et al, 2013; Zhang et al, 2013), whereas the mPFC
is linked to subjective value of objects and choices (Glascher
et al, 2009; Haber and Knutson, 2010). Thus, greater
disturbances in connectivity—and, particularly, rapid
attenuation of connectivity—between the striatum and these
frontal regions may be related to impairments in reward
valuation and goal-directed behavior. Because a key
component of BATD is to increase engagement with valued
behavior (Dimidjian et al, 2011), it may be the case that this
treatment functions especially well for patients with greater
deficits in reward-related frontostriatal connectivity. That is,
BATD may be effective in remediating deficits associated
with anticipatory processing of rewards, effort valuation, and
decision-making to engage in goal-directed behavior. This
interpretation suggests a framework for understanding a
potential pathway to personalized MDD interventions:
patients with greater deficits in connectivity, and the capacity
to sustain connectivity, in reward-processing regions may be
good candidates for treatments that target reward network
functioning and related behaviors, whereas other treatments
may be more suited to patients with different patterns of
neural connectivity. Clearly, larger-scale studies that evaluate
patient responses to a number of different treatment
modalities will be needed to fully evaluate this framework
(McGrath et al, 2014).
Although the majority of our results show that patients
with connectivity patterns that were more divergent from
controls showed a more improved response to BATD, one
connectivity pattern reflected better response in individuals
who were more similar to controls. Specifically, less
connectivity attenuation between the right putamen seed
and right OFC/temporal pole (BA47) during reward
anticipation was associated with greater declines in BDI
total scores (ie, those with less dropoff in connectivity
responded better to treatment). Previous studies have shown
MDD to be characterized by altered OFC function during
reward selection (Smoski et al, 2009) and receipt of
unexpected rewards (Segarra et al, 2016). It may be the case
that patients with MDD with some preservation of reward
network function (ie, those whose connectivity patterns look
more similar to controls) respond better to BATD treatment.
Although the majority of our findings are suggestive of
BATD being particularly effective for patients with greater
brain reward network disturbances, it is likely that some
motivational capacity may be needed to fully benefit from
this psychotherapy. This interpretation parallels results from
our previous report in this sample (Carl et al, 2016), where
we showed that patients with less attenuation of activation in
the ACC during reward outcomes were more responsive to
BATD. Although MDD and control groups did not differ in
activation magnitude in this region, prior research suggests
that increased baseline ACC activation is predictive of
positive treatment response in MDD (Fu et al, 2013;
Pizzagalli, 2011). Taken together, these findings highlight
the relevance of attenuation (or lack thereof) of frontocin-
gulate neural activation and connectivity in predicting
response to antidepressant treatment.
The present study evaluated a treatment that targets
decreased motivation as a core feature of MDD. Anhedonic
symptoms are often the most difficult MDD symptom to
treat and may represent a critical vulnerability factor for
various psychiatric disorders (Hasler et al, 2004; Pizzagalli
et al, 2005). Although the majority of neural connectivity
treatment predictors in this study involved BDI total scores,
the largest effect sizes were observed for prediction of change
in BDI anhedonia subscale scores (ie, BDI anhedonia
subscale scores accounted for a larger percent of the
between-person variance in treatment response than BDI
total scores). This suggests that reward system connectivity
may be a particularly robust predictor of changes in
anhedonic symptoms.
It is notable that analyses of global connectivity yielded
only one finding that was predictive of treatment response,
whereas there were four patterns reflective of connectivity
attenuation that were predictive of treatment response. This
suggests the importance of examining temporal changes in
neural connectivity as an MDD endophenotype that is
particularly relevant to predicting antidepressant treatment
response. In addition, connectivity patterns that differen-
tiated MDD patients from controls, as well as those that were
predictive of treatment response, were primarily related to
anticipatory processing. Reaction times during rewarded
trials—reflecting anticipatory processing/motivation—were
also predictive of treatment response (Supplementary
Materials VII). These findings suggest that anhedonia in
MDD may be more strongly linked to components of
appetitive motivation than hedonic processing. Further,
neural and behavioral methods for assessing anticipatory
processing may be powerful predictors of treatment response
in MDD.
Previous studies of sustained neural responses in MDD
(Heller et al, 2009, 2013) applied beta series correlation
methods wherein individual trials are estimated, whereas the
current study used a gPPI approach to average beta estimates
across trials for each condition to compare changes in
connectivity from the first to the second run of the task. In
this regard, the gPPI approach may be interpreted to reflect
differential habituation in the MDD group. (We thank an
anonymous reviewer for this additional interpretation.)
Future work should examine whether habituation to the
task or cognitive fatigue arising during multiple administra-
tions may contribute to differential changes in connectivity
in MDD during scanning. In addition, our analytic approach
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of evaluating group by run interaction terms emphasizes
patterns of connectivity in the MDD group that are opposite
to controls. Although this approach was designed to
underscore connectivity patterns in the MDD group that
were atypical, it is not sensitive to identify patterns where
attenuation of connectivity may be similar in both MDD
and control groups. Despite these differences in modeling
approaches, our findings are consistent with existing
evidence (Heller et al, 2009, 2013) and provide additional
support for investigating temporal trajectories of brain
connectivity patterns.
Limitations. Limitations of the current study to address in
future research include incorporating additional task trials
(eg, reward loss) or experimental paradigms to more fully
assess different aspects of reward processing, such as valence
or arousal (eg, Liu et al, 2011). The present study also lacked
a comparison treatment condition (eg, a different psy-
chotherapy modality or a psychopharmacologic treatment).
In this regard, our findings cannot be attributed specifically
to BATD. In addition, post-treatment scans were not
acquired, and thus it was not possible to examine the effects
of BATD on reward-related connectivity. Likewise, long-
itudinal clinical follow-up data would be needed to address
neural predictors of MDD relapse. Finally, because we
recruited based on relatively mild depression scores (HAMD
⩾ 15), future studies should replicate these findings in
samples with greater symptom severity.
CONCLUSIONS
In summary, the current study found that functional
connectivity in reward-processing brain regions in the
context of a reward-processing task was predictive of
response to BATD, a psychotherapy modality that improves
motivation and engagement with patient-specific goals.
Evaluation of connectivity attenuation yielded four findings
that were predictive of treatment response, underscoring the
relevance of the temporal dynamics of frontostriatal
connectivity for predicting response to this treatment
modality. These findings extend the emerging framework
of MDD that emphasizes decreased capacity to sustain neural
response to hedonic stimuli in the pathophysiology of the
disorder (Carl et al, 2016; Heller et al, 2009, 2013) to the
domain of treatment prediction. More generally, combined
with our prior examination of resting state predictors of
BATD response in a subset of this sample (Crowther et al,
2015) and emerging evidence addressing neural predictors of
response to other antidepressant treatment modalities (see
Dichter et al, 2014 for a review), these findings contribute to
the growing body of literature addressing pretreatment
neuroimaging endophenotypes as predictors of antidepres-
sant treatment response (McGrath et al, 2013). The ultimate
goal of such studies is to improve response rates to available
MDD treatments by developing predictive models of
treatment response (Kapur et al, 2012).
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